Sunday, November 09, 2008

Coming soon---ceftobiprole

Via The Annals of Pharmacotherapy:

Ceftobiprole medocaril is an extended-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus spp., vancomycin-resistant Staphylococcus aureus, penicillin-resistant Streptococcus pneumoniae, vancomycin-resistant Enterococcus faecalis, Enterobacteriaceae, and Pseudomonas aeruginosa.

The major hole in this 5th generation cephalosporin? Those pesky ESBLs.

Note: Many VREs are Enterococcus faecium. Ceftobiprole is apparently not active against E. faecium.

No comments: